Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new prilosec clinical trials listings will be included here shortly after becoming available to us.
Clinical Trials on prilosec
- A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Subjects.
Status: Recruiting, Condition Summary: Healthy - Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
Status: Recruiting, Condition Summary: Gastric Acid - Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately
Status: Active, not recruiting, Condition Summary: Peptic Ulcer Disease - Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression
Status: Completed, Condition Summary: Normal Healthy Subject Population - Reflux Esophagitis Phase III Study (Maintenance Treatment)
Status: Completed, Condition Summary: Reflux Esophagitis - Ulcer Prevention II
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - Nexium Study To Suppress Nausea During Chemotherapy
Status: Active, not recruiting, Condition Summary: Nausea - Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
Status: Completed, Condition Summary: Erosive Esophagitis - Prevention of Gastric Ulcers
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: GERD - Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously
Status: Completed, Condition Summary: GERD - Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: Gastroesophageal Reflux Disease (GERD) - Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
Status: Completed, Condition Summary: Ulcers; Upper GI Symptoms - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: Gastroesophageal Reflux Disease (GERD) - A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
Status: Completed, Condition Summary: Symptomatic Gastroesophageal Reflux Disease (sGERD) - A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(COMPLETED)
Status: Completed, Condition Summary: Gastric Acid; Human Experimentation - A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
Status: Completed, Condition Summary: Arthritis - A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (COMPLETED)
Status: Completed, Condition Summary: Gastric Acid; Human Experimentation - A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers